跳至主要内容
临床试验/EUCTR2020-005682-13-NL
EUCTR2020-005682-13-NL进行中(未招募)1 期

Exploratory study into age-related immunological differences related to immunogenicity in influenza vaccination and herpes zoster vaccination - INFLUENZA-SHINGRIX

Radboudumc0 个研究点目标入组 140 人开始时间: 2021年1月5日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
Radboudumc
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Age between 18-35 years old OR age =65 years old
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

排除标准

  • Known allergy to (components of) the influenza or herpes zoster vaccine
  • Immunocompromised subjects
  • Previous herpes zoster vaccination in the last year
  • Receipt of any vaccination 1 month prior to the start of the study or plans to receive any other vaccination until the last study visit
  • Chronic use of systemic drugs other than oral contraceptives
  • Use of NSAIDS less than 4 weeks prior to the start of the study
  • Acute or active illness within two weeks prior to the start of the study
  • Pregnant, breastfeeding or planning to become pregnant within the study period

研究者

发起方
Radboudumc

相似试验